Liraglutide reduces body weight and adiposity but does not significantly impact brown adipose tissue activity in humans
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
Abstract
Liraglutide significantly reduced body weight and adiposity in obese individuals, but did not show a convincing effect on brown adipose tissue (BAT) activity or recruitment.